|
HELZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.105427357601E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.52970994047064E-14 |
| Normal-vs-Stage2 |
1.33709709970731E-11 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.818200E-01 |
| Stage1-vs-Stage3 |
5.152400E-02 |
| Stage1-vs-Stage4 |
6.032600E-04 |
| Stage2-vs-Stage3 |
7.751700E-02 |
| Stage2-vs-Stage4 |
4.922500E-03 |
| Stage3-vs-Stage4 |
1.836190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62736490949555E-12 |
| Normal-vs-AfricanAmerican |
4.84930000044237E-07 |
| Normal-vs-Asian |
1.97131200252443E-12 |
| Caucasian-vs-AfricanAmerican |
1.838800E-01 |
| Caucasian-vs-Asian |
6.796400E-01 |
| AfricanAmerican-vs-Asian |
3.532800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62636570877339E-12 |
| Normal-vs-Female |
1.08801856413265E-14 |
| Male-vs-Female |
3.777200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70741198957103E-12 |
| Normal-vs-Age(41-60Yrs) |
4.21884749357559E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62581059726108E-12 |
| Normal-vs-Age(81-100Yrs) |
1.97449000000072E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.530200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.036230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.199400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.609600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.683600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.751200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.166600E-04 |
| Classical-VS-Follicular |
6.070800E-01 |
| Classical-VS-Other |
5.008800E-01 |
| Classical-VS-Normal |
1.78423942287509E-12 |
| Tall-VS-Follicular |
1.339530E-03 |
| Tall-VS-Other |
3.725600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.691600E-01 |
| Follicular-VS-Normal |
1.72661884789704E-12 |
| Other-VS-Normal |
1.585250E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0325074129014E-14 |
| Normal-vs-N1 |
4.18665102586147E-13 |
| N0-vs-N1 |
4.110400E-01 |
|
|
